Company / Free Cash Flow per Share
BIOCRYST PHARMACEUTICALS INC Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.58
FY2025
5-year range
-$0.88 / $1.58
FY2021-FY2025
Trend
+713.7%
vs FY2024
Sector context
#39 of 192
Health Care
What the data says
Free Cash Flow per Share changed +714% YoY in FY2025, a notable deviation from the 9-year average annual change of +86%.
Based on SEC 10-K filings.
1.58 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.51 to $1.58 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 192This company $1.58 Sector average $3.32
▼
-52.5% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 713.7% year-over-year.
- Ranks #39 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.58 | +713.7% |
| FY2024 | -$0.26 | +49.2% |
| FY2023 | -$0.51 | +42.3% |
| FY2022 | -$0.88 | -8.8% |
| FY2021 | -$0.81 | +0.5% |
| FY2020 | -$0.81 | -4.2% |
| FY2019 | -$0.78 | +13.6% |
| FY2018 | -$0.90 | -60.2% |
| FY2017 | -$0.56 | +29.8% |
| FY2016 | -$0.80 | -215.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026